<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/~/media/Files/S/staar-surgical/XSL/rss_xsl.xsl"?> 
<rss version="2.0" xmlns:dt="http://xsltsl.org/date-time">
 <channel>
  <title>RSS - Staar Surgical - Press Releases </title>
  <link>https://investors.staar.com/rss/press-releases</link>
  <language>en</language>
<webMaster>Staar Surgical</webMaster>
<image>
<url>https://investors.staar.com/~/media/Images/S/staar-surgical/logo/logo-dark.svg</url>
</image>
<item>
<title><![CDATA[STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that it will release financial results and a letter to shareholders for the third quarter ended October 2, 2026, on Wednesday, November 4, 2026, after the market close. The Company will also host an earnings call...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/10-21-2026-210113498</link>
<pubDate>Wed, 21 Oct 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 21 Oct 2026 21:01:16 GMT</publishDate>
<guid>{FE46D89B-C67D-48C9-930D-34126FD33B8F}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Names Andrew Pilon as Vice President of Business Development]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced the appointment of Andrew Pilon, O.D. as Vice President of Business Development. Pilon will report to STAAR President and Chief Executive Officer Warren Foust and will work closely with the Company’ s senior...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/10-08-2026-201416848</link>
<pubDate>Thu, 08 Oct 2026 20:14:00 GMT</pubDate>
<publishDate>Thu, 08 Oct 2026 20:14:18 GMT</publishDate>
<guid>{ECD4BB26-6D5F-4FC4-B484-4C6BB3DAF2DC}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Board Approves $50 Million Share Repurchase Authorization]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO™ family of Implantable Collamer ® Lenses for vision correction, today announced that its Board of Directors, at a regularly scheduled meeting, authorized a share repurchase program under which the Company may repurchase up to $50 million of its outstanding common stock.]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-24-2026-210110425</link>
<pubDate>Thu, 24 Sep 2026 21:01:00 GMT</pubDate>
<publishDate>Thu, 24 Sep 2026 21:01:12 GMT</publishDate>
<guid>{EF8BD713-73AC-4A63-9B58-8043D34C2705}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction]]></title>
<description><![CDATA[The report examines patient sentiment, procedure volume trends, and clinical practice patterns across Japan, China, South Korea, the United States, Germany, Spain, and the UK and Ireland. The STAAR Surgical team will be available to discuss the results of the report at the upcoming 44th Congress of the ESCRS in London from September 11– 15, 2026, where the Company...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-10-2026-120022923</link>
<pubDate>Thu, 10 Sep 2026 12:00:00 GMT</pubDate>
<publishDate>Thu, 10 Sep 2026 12:00:25 GMT</publishDate>
<guid>{883CA235-B69A-47D1-8840-E3242E791C70}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced the appointment of David Bailey as Chief Commercial Officer.  "As our former President and CEO, he launched commercialization of the ICL across Asia and championed development of the central port, the innovation...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-08-2026-203320099</link>
<pubDate>Tue, 08 Sep 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 09 Sep 2026 20:33:21 GMT</publishDate>
<guid>{7175C232-331D-41E3-94C7-0A2FC2B86B55}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced the appointment of Ben Park, Ph.D., as Chief Technology Officer. Park will join STAAR's Executive Committee and report to Warren Foust, President and Chief Executive Officer. Park built and led a global...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-02-2026-210122542</link>
<pubDate>Wed, 02 Sep 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 02 Sep 2026 21:01:25 GMT</publishDate>
<guid>{8F9699E1-BDB3-4A95-929B-82C729BE9E03}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Reports Second Quarter 2026 Results]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO™ family of Implantable Collamer ® Lenses for vision correction, today reported results for the second quarter ended July 3, 2026.. Second Quarter 2026 Financial Overview. Net sales of $93.5 million, up 111% Y/Y Net sales excluding China of $41.2 million, up 6.0% Y/Y China sales of $52.3 million...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/08-12-2026-210127260</link>
<pubDate>Wed, 12 Aug 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 12 Aug 2026 21:02:53 GMT</publishDate>
<guid>{A7330ED6-4D06-4427-9D07-6000A947FF43}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that following an extensive global search, its Board of Directors has appointed Warren Foust as President and Chief Executive Officer and a new member of the Board of Directors, effective August 4, 2026.]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/08-04-2026-210656803</link>
<pubDate>Tue, 04 Aug 2026 21:05:00 GMT</pubDate>
<publishDate>Tue, 04 Aug 2026 21:07:56 GMT</publishDate>
<guid>{38D87318-50C8-44FF-8848-525AF8A87B2C}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that it will release financial results in combination with a shareholder letter for the second quarter ended July 3, 2026, on Wednesday, August 12, 2026, after the market close. The Company will also host an...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/08-04-2026-210126674</link>
<pubDate>Tue, 04 Aug 2026 21:01:00 GMT</pubDate>
<publishDate>Tue, 04 Aug 2026 21:02:53 GMT</publishDate>
<guid>{EFE4D4D6-0AC5-47BD-91D7-ACA2CEDE6994}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026]]></title>
<description><![CDATA[The Company delivered strong second quarter net sales, led by sequential growth in China, solid growth across the broader Asia-Pacific region, and double-digit percentage growth in the Americas. In the EMEA region, net sales declined by a low single-digit percentage, reflecting ongoing turmoil in the Middle East; however, excluding the Middle East, EMEA...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/07-16-2026-210120790</link>
<pubDate>Thu, 16 Jul 2026 21:01:00 GMT</pubDate>
<publishDate>Thu, 16 Jul 2026 21:01:23 GMT</publishDate>
<guid>{EE4E22A0-D6E9-42F4-94BF-B9746671EA03}</guid>
<isalertable>False</isalertable>
</item>

  
 </channel>
</rss>